You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Castration-Resistant Prostatic Cancer

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Oropharyngeal Cancer Trial in Shanghai (Toxicities reduced treatment, Conventional treatment)

Recruiting
  • Oropharyngeal Cancer
  • Toxicities reduced treatment
  • Conventional treatment
  • Shanghai, Shanghai, China
    Eye & ENT Hospital of Fudan University
Nov 26, 2023

Cell-free DNA in Hereditary And High-Risk Malignancies

Recruiting
  • Hereditary Cancer Syndrome
  • Next generation sequencing (NGS)
  • Vancouver, British Columbia, Canada
  • +6 more
Feb 14, 2022

Endometrial Cancer, Survivorship Trial in Winston-Salem (PREVENT Cardiovascular Health Assessment Tool, Survey, Interview

Not yet recruiting
  • Endometrial Cancer
  • Survivorship
  • PREVENT Cardiovascular Health Assessment Tool
  • +2 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Apr 6, 2023

Mantle Cell Lymphoma Trial in Houston (Acalabrutinib)

Recruiting
  • Mantle Cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Aug 22, 2022

Rectal Cancer Trial in Frankfurt (drug, radiation, procedure)

Recruiting
  • Rectal Cancer
  • Kineret 100 MG in 0.67 ML Prefilled Syringe
  • +3 more
  • Frankfurt, Germany
    University Hospital Goethe University Frankfurt
Aug 23, 2022

NSCLC Trial in Iowa City (Paclitaxel, Carboplatin, Ascorbic Acid)

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Iowa City, Iowa
    Holden Comprehensive Cancer Center
Aug 17, 2022

Tislelizumab, Bevacizumab, Oxaliplatin Trial in Beijing (Tislelizumab+Bevacizumab+Oxaliplatin+Capecitabine)

Recruiting
  • Tislelizumab
  • +7 more
  • Beijing, China
    Lin Yang
Jul 21, 2023

Breast Cancer, Triple Negative Breast Cancer, Cardiovascular Complications Trial in Durham, Winston-Salem, Richmond (drug,

Recruiting
  • Breast Cancer
  • +2 more
  • Adenosine Stress Cardiac Magnetic Resonance Imaging
  • +4 more
  • Durham, North Carolina
  • +2 more
Aug 11, 2022

Locally Advanced or Metastatic NSCLC Trial in Worldwide (Trastuzumab Deruxtecan, Cisplatin, Carboplatin)

Recruiting
  • Locally Advanced or Metastatic Non-Small Cell Lung Cancer
  • Trastuzumab Deruxtecan
  • +4 more
  • Anchorage, Alaska
  • +148 more
Aug 11, 2022

Recurrent Lymphoma, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Irinotecan,

Active, not recruiting
Has Results
  • Recurrent Lymphoma
  • +5 more
  • Birmingham, Alabama
  • +19 more
Oct 20, 2022

Prostate Cancer Trial (Focal Laser Ablation)

Not yet recruiting
  • Prostate Cancer
  • Focal Laser Ablation
  • (no location specified)
Sep 14, 2023

Ocular Rosacea, Antimicrobial Resistance Trial in San Francisco (Doxycycline 40 MG Oral Tablet, Doxycycline 100 MG Oral Tablet,

Not yet recruiting
  • Ocular Rosacea
  • Antimicrobial Resistance
  • Doxycycline 40 MG Oral Tablet
  • +2 more
  • San Francisco, California
    University of California, San Farncisco
Jul 7, 2022

Locally Advanced Solid Tumors, Metastatic Solid Tumors Trial in Edmonton ([131]I-IAZA)

Withdrawn
  • Locally Advanced Solid Tumors
  • Metastatic Solid Tumors
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Jul 7, 2022

Head Neck Cancer Trial in Singapore (carboplatin,, cisplatin, gemcitabine HCl)

Active, not recruiting
  • Head and Neck Cancer
  • Singapore, Singapore
    National Cancer Centre - Singapore
Sep 27, 2022

Gastrointestinal Cancer Trial in Hangzhou (Pemigatinib Pill)

Recruiting
  • Gastrointestinal Cancer
  • Pemigatinib Pill
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Sep 26, 2022

Breast Cancer Stage IV, Unresectable Locally Advanced Invasive Breast Cancer, Metastatic Invasive Breast Cancer Trial in Boston

Completed
Has Results
  • Breast Cancer Stage IV
  • +2 more
  • Boston, Massachusetts
  • +1 more
Oct 21, 2022

Prostate Cancer Trial in United States (Degarelix, stereotactic body radiosurgery (SBRT))

Active, not recruiting
  • Prostate Cancer
  • Miami, Florida
  • +9 more
Mar 1, 2022

Exceptional Responders With Pancreatic Cancer to Chemotherapy

Enrolling by invitation
  • Solid Tumor Neoplasms
  • Standard of Care Chemotherapy
  • Los Angeles, California
    The Pancreatic Cancer Treatment Center of Los Angeles
Jan 30, 2023

Cognitive Impairment, Hematologic Malignancy Trial in Birmingham (Modified ketogenic diet using an exogenous ketogenic formula,

Recruiting
  • Cognitive Impairment
  • Hematologic Malignancy
  • Modified ketogenic diet using an exogenous ketogenic formula
  • Online cognitive training
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 31, 2023

LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study

Recruiting
  • Cancer
  • +9 more
    • Edmonton, Alberta, Canada
      Edith Pituskin
    Nov 30, 2022

    Gut Microbiome in Lynch Syndrome and Other Hereditary Colonic

    Recruiting
    • Lynch Syndrome
    • Hereditary Colonic Polyposis Syndromes
    • colonic biopsies
    • questionnaires
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Mar 1, 2022

    Clonal Cytopenia of Undetermined Significance Trial in Columbus (procedure, drug, other)

    Recruiting
    • Clonal Cytopenia of Undetermined Significance
    • Biospecimen Collection
    • +6 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Dec 12, 2022

    Lymphedema Trial in Istanbul (High intensity resistive exercise, Low intensity resistive exercise)

    Active, not recruiting
    • Lymphedema
    • High intensity resistive exercise
    • Low intensity resistive exercise
    • Istanbul, Fatih, Turkey
      Istanbul University
    Dec 6, 2022

    Metastatic Malignant Tumor in the Brain, Stage IV NSCLC AJCC v7 Trial in Houston (procedure, biological, other, radiation)

    Recruiting
    • Metastatic Malignant Neoplasm in the Brain
    • Stage IV Non-Small Cell Lung Cancer AJCC v7
    • Cognitive Assessment
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 12, 2022

    ALK-positive NSCLC in Sweden: Sequencing of ALK Tyrosine Kinase

    Completed
    Has Results
    • ALK-positive NSCLC
    • Sollentuna, Sweden
      Pfizer Innovations AB
    Mar 14, 2022